Cutler Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Cutler Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,000	Closed	-$1K	–	4937
2022 Q4	$1K	Hold	4,000	–	–	﹤0.01%	4229
2022 Q3	$9K	Hold	4,000	–	–	﹤0.01%	3232
2022 Q2	$6K	Buy	+4,000	New	+$44.1K	﹤0.01%	3637
2021 Q4	–	Sell	-2,000	Closed	-$2K	–	6320
2021 Q3	$2K	Sell	2,000 -14,800	-88%	-$472K	﹤0.01%	5149
2021 Q2	$9K	Buy	16,800 +3,100	+23%	+$120K	﹤0.01%	4025
2021 Q1	$66K	Buy	13,700 +3,500	+34%	+$163K	﹤0.01%	2116
2020 Q4	$44K	Buy	10,200 +4,500	+79%	+$267K	﹤0.01%	2101
2020 Q3	$14K	Buy	5,700 +1,400	+33%	+$68.6K	﹤0.01%	2758
2020 Q2	$42K	Sell	4,300 -12,900	-75%	-$690K	﹤0.01%	1867
2020 Q1	$29K	Sell	17,200 -49,600	-74%	-$2.75M	﹤0.01%	2084
2019 Q4	$521K	Buy	+66,800	New	+$3.17M	0.03%	435

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Cutler Group's DCPH Position: Q1 2024 in Review

Cutler Group reduced its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 40% in Q1 2024, selling an estimated $3.08K and leaving 300 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Cutler Group first reported a position in DCPH in Q3 2019 and has held it in 19 quarters since. The position peaked at $1.97M in Q4 2019. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

Cutler Group held 300 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $4K as of Q1 2024.
Cutler Group sold 200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $3.08K.
Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1675 holding.
Cutler Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and has held it in 19 quarters since.
Cutler Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.97M in Q4 2019.
177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.